STRONGBRIDGE BIOPHARMA plc Amortization of Intangible Assets
STRONGBRIDGE BIOPHARMA plc reported Amortization of Intangible Assets of $1.25 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for the quarter ending 2021-06-30 was $1.25M, a 0.00% change year-over-year.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for the quarter ending 2021-03-31 was $1.26M, a 0.00% change year-over-year.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for the quarter ending 2020-12-31 was $1.26M, a 0.00% change year-over-year.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for the quarter ending 2020-09-30 was $1.25M, a 0.00% change year-over-year.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for fiscal 2020 was $5.02M, a 0.00% change from fiscal 2019.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for fiscal 2019 was $5.02M, a 30.12% decline from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for fiscal 2018 was $7.19M, a 43.11% increase from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc amortization of intangible assets for fiscal 2017 was $5.02M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2021-06-30 | $1.25M 10-Q · filed 2021-08-05 | $2.51M 10-Q · filed 2021-08-05 | $3.77M derived: sum of 3 quarters · filed 2021-08-05 | $5.02M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $1.26M 10-Q · filed 2021-05-12 | $2.51M derived: sum of 2 quarters · filed 2021-05-12 | $3.77M derived: sum of 3 quarters · filed 2021-05-12 | $5.02M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $1.26M 10-K · filed 2021-03-03 | $2.51M derived: sum of 2 quarters · filed 2021-03-03 | $3.77M derived: sum of 3 quarters · filed 2021-08-05 | $5.02M 10-K · filed 2021-03-03 |
| 2020-09-30 | $1.25M 10-K · filed 2021-03-03 | $2.51M derived: sum of 2 quarters · filed 2021-08-05 | $3.77M 10-Q · filed 2020-10-29 | $5.02M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $1.25M 10-Q · filed 2021-08-05 | $2.51M 10-Q · filed 2021-08-05 | $3.77M derived: sum of 3 quarters · filed 2021-08-05 | $5.02M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.26M 10-Q · filed 2021-05-12 | $2.51M derived: sum of 2 quarters · filed 2021-05-12 | $3.77M derived: sum of 3 quarters · filed 2021-05-12 | $5.02M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.26M 10-K · filed 2021-03-03 | $2.51M derived: sum of 2 quarters · filed 2021-03-03 | $3.77M derived: sum of 3 quarters · filed 2021-03-03 | $5.02M 10-K · filed 2021-03-03 |
| 2019-09-30 | $1.25M 10-K · filed 2021-03-03 | $2.51M derived: sum of 2 quarters · filed 2021-03-03 | $3.77M 10-Q · filed 2020-10-29 | $5.44M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | $1.25M 10-K · filed 2021-03-03 | $2.51M 10-Q · filed 2020-08-04 | $4.18M derived: sum of 3 quarters · filed 2021-03-03 | $6.06M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | $1.26M 10-K · filed 2021-03-03 | $2.93M derived: sum of 2 quarters · filed 2021-03-03 | $4.80M derived: sum of 3 quarters · filed 2021-03-03 | $6.67M derived: sum of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | $1.67M 10-K · filed 2020-02-28 | $3.55M derived: sum of 2 quarters · filed 2020-02-28 | $5.42M derived: sum of 3 quarters · filed 2020-02-28 | $7.19M 10-K · filed 2021-03-03 |
| 2018-09-30 | $1.88M 10-K · filed 2020-02-28 | $3.75M derived: sum of 2 quarters · filed 2020-02-28 | $5.52M 10-Q · filed 2019-11-07 | $6.77M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $1.87M 10-K · filed 2020-02-28 | $3.64M 10-Q · filed 2019-07-31 | $4.90M derived: sum of 3 quarters · filed 2020-02-28 | $6.15M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $1.77M 10-K · filed 2020-02-28 | $3.02M derived: sum of 2 quarters · filed 2020-02-28 | $4.28M derived: sum of 3 quarters · filed 2020-02-28 | $5.54M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.51M derived: sum of 2 quarters · filed 2020-02-28 | $3.77M derived: sum of 3 quarters · filed 2020-02-28 | $5.02M 10-K · filed 2020-02-28 |
| 2017-09-30 | $1.26M 10-Q · filed 2018-10-31 | $2.51M derived: sum of 2 quarters · filed 2018-10-31 | $3.77M 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $1.25M 10-Q · filed 2018-08-08 | $2.51M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $1.26M 10-Q · filed 2018-05-10 |